CA2096970C - Anilide derivative - Google Patents

Anilide derivative

Info

Publication number
CA2096970C
CA2096970C CA002096970A CA2096970A CA2096970C CA 2096970 C CA2096970 C CA 2096970C CA 002096970 A CA002096970 A CA 002096970A CA 2096970 A CA2096970 A CA 2096970A CA 2096970 C CA2096970 C CA 2096970C
Authority
CA
Canada
Prior art keywords
compound
carbon atoms
group
acetamide
diisopropylphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002096970A
Other languages
English (en)
French (fr)
Other versions
CA2096970A1 (en
Inventor
Masakazu Sato
Yutaka Kawashima
Katsuo Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of CA2096970A1 publication Critical patent/CA2096970A1/en
Application granted granted Critical
Publication of CA2096970C publication Critical patent/CA2096970C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids
    • C07C327/20—Esters of monothiocarboxylic acids
    • C07C327/32—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002096970A 1990-11-26 1991-11-21 Anilide derivative Expired - Fee Related CA2096970C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPHEI-2-322136 1990-11-26
JP32213690 1990-11-26

Publications (2)

Publication Number Publication Date
CA2096970A1 CA2096970A1 (en) 1992-05-27
CA2096970C true CA2096970C (en) 1998-07-14

Family

ID=18140332

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002096970A Expired - Fee Related CA2096970C (en) 1990-11-26 1991-11-21 Anilide derivative

Country Status (11)

Country Link
US (1) US5475130A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0559898B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP2650096B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR0169501B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE137744T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2096970C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE69119434T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK0559898T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2088574T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3020257T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO1992009572A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5668136A (en) * 1990-09-25 1997-09-16 Eisai Co., Ltd. Trisubstituted benzene derivatives, composition and methods of treatment
CA2115915A1 (en) * 1992-07-20 1994-02-03 Kenji Hayashi Benzene derivatives
AU1076695A (en) * 1993-11-25 1995-06-13 Taisho Pharmaceutical Co., Ltd. Composition of pharmaceutical preparation improved in peroral absorbability
FR2729665B1 (fr) * 1995-01-19 1997-04-18 Pf Medicament Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique
FR2741619B1 (fr) * 1995-11-28 1998-02-13 Pf Medicament Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
EP0983763A4 (en) * 1997-04-01 2003-03-19 Taisho Pharmaceutical Co Ltd RECONSTRUCTION PREVENTION MEDIUM
EP0983764A4 (en) * 1997-04-01 2002-07-03 Taisho Pharmaceutical Co Ltd PROFILEACTICAL MEANS OF HEART CHEMISTRY
PL368843A1 (en) * 2001-08-28 2005-04-04 Sankyo Company, Limited Medicinal compositions containing angiotensin ii receptor antagonist
US20050119314A1 (en) * 2002-04-05 2005-06-02 Sankyo Company, Limited Pharmaceutical composition comprising an ACAT inhibitor and an insulin resistance reducing agent
EP1689383B1 (en) 2003-11-19 2012-10-31 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
MX2007005129A (es) * 2004-10-27 2007-09-11 Daiichi Sankyo Co Ltd Compuesto de benceno que tiene 2 o mas sustituyentes.
WO2008014199A2 (en) * 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 receptor
EA200900403A1 (ru) * 2006-09-25 2009-10-30 Бёрингер Ингельхайм Интернациональ Гмбх Соединения, которые модулируют рецептор св2
WO2009061652A1 (en) * 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
WO2010005782A1 (en) * 2008-07-10 2010-01-14 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the cb2 receptor
MX2011002904A (es) 2008-09-25 2011-04-11 Boehringer Ingelheim Int Compuestos de sulfonilo que modulan selectivamente el receptor de cb2.
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
US8299103B2 (en) * 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja) 2009-06-16 2015-07-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節するアゼチジン２−カルボキサミド誘導体
WO2011037795A1 (en) * 2009-09-22 2011-03-31 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
WO2011088015A1 (en) 2010-01-15 2011-07-21 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8329735B2 (en) 2010-03-05 2012-12-11 Boehringer Ingelheim International Gmbh Tetrazole compounds which selectively modulate the CB2 receptor
US8846936B2 (en) 2010-07-22 2014-09-30 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the CB2 receptor
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878248A (en) * 1971-05-03 1975-04-15 Monsanto Co Substituted alpha, alpha-dichloro-methane-sulfenyl chlorides
JPS5439028A (en) * 1977-08-31 1979-03-24 Hokko Chem Ind Co Ltd Acetanilide derivatives and bactericides containing the same for agricultural and horticultural, uses
US4329363A (en) * 1978-09-08 1982-05-11 Merck & Co., Inc. Substituted mercapto acid amides and their use
US4623662A (en) * 1985-05-23 1986-11-18 American Cyanamid Company Antiatherosclerotic ureas and thioureas
FR2540495B1 (fr) * 1983-02-07 1986-02-14 Roussel Uclaf Nouveaux derives de o-mercaptopropanamide et de ses homologues, leur procede de preparation, leur application comme medicaments, les compositions les renfermant et les nouveaux intermediaires obtenus
GB2149394B (en) * 1983-07-19 1986-09-24 American Cyanamid Co Ureas
US4859707A (en) * 1983-08-23 1989-08-22 Key Pharmaceuticals, Inc. Sulfur-substituted phenylacetamides
EP0190682B1 (en) * 1985-02-04 1990-09-12 G.D. Searle & Co. Novel disubstituted 4-hydroxyphenylthio anilides
ZA871597B (en) * 1986-03-24 1988-10-26 Warner Lambert Co Substituted anilides of oleic,linoleic,or linolenic acid as inhibitors of acyl-coa:cholestrol acyltransferase
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
EP0361365A1 (en) * 1988-09-30 1990-04-04 E.R. SQUIBB & SONS, INC. Aminobenzoic and aminocyclohexane-carboylic acid compounds, compositions, and their method of use
MX22406A (es) * 1989-09-15 1994-01-31 Pfizer Nuevos derivados de n-aril y n-heteroarilamidas y urea como inhibidores de acil coenzima a: acil transferasa del colesterol (acat).

Also Published As

Publication number Publication date
ATE137744T1 (de) 1996-05-15
WO1992009572A1 (fr) 1992-06-11
DE69119434T2 (de) 1996-09-12
ES2088574T3 (es) 1996-08-16
DK0559898T3 (da) 1996-08-19
EP0559898B1 (en) 1996-05-08
EP0559898A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1994-01-12
JP2650096B2 (ja) 1997-09-03
US5475130A (en) 1995-12-12
KR930702254A (ko) 1993-09-08
GR3020257T3 (en) 1996-09-30
KR0169501B1 (ko) 1999-03-20
EP0559898A1 (en) 1993-09-15
DE69119434D1 (de) 1996-06-13
CA2096970A1 (en) 1992-05-27

Similar Documents

Publication Publication Date Title
CA2096970C (en) Anilide derivative
RU2025123C1 (ru) Ингибиторы пролин- или лизингидроксилазы, фибро- или иммунодепрессанты, лечебное средство при расстройствах метаболизма коллагена или коллагеноподобных веществ
KR0143565B1 (ko) 피발산의 p-치환된 페닐 에스테르 유도체, 그의 제조 방법 및 이를 포함하는 조성물.
US5665777A (en) Biphenyl hydroxamate inhibitors of matrix metalloproteinases
EP1149063B1 (en) Ureido-thiobutyric acid derivatives as ppar-agonists
EP2482815B1 (en) Antiinflammatory 2-oxothiazoles and 2-oxooxazoles
EA007649B1 (ru) Ингибиторы гистондеацетилазы, вызывающие дифференцировку клеток, и их применение
WO2004110418A2 (en) Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
KR100417275B1 (ko) 2,3,5-트리메틸-4-히드록시아닐리드유도체,이의제조방법및이의치료용도
EP0463638A1 (en) Aminophenyl derivatives
SK282995B6 (sk) Zlúčenina na inhibíciu metaloproteázy a prostriedok s jej obsahom
KR20000069139A (ko) 프로테아제 억제제인 아미노구아니딘 및 알콕시구아니딘
CA2552942A1 (en) New compounds, methods for their preparation and use thereof
EP0633254A1 (en) Novel isoxazole derivative and salt thereof
JPH0662556B2 (ja) 新規アニリド
Hu et al. Design, synthesis, and biological evaluation of histone deacetylase inhibitors possessing glutathione peroxidase-like and antioxidant activities against Alzheimer’s disease
US4670469A (en) Hydroxamic acid and pharmaceutical preparations containing the same
US4981853A (en) Heterocyclic amides
WO2006063294A2 (en) Novel inhibitors of histone deacetylase for the treatment of disease
JP2842147B2 (ja) Ａｃａｔ阻害剤
JPH05502233A (ja) 薬理学的に活性なアミドカルボキシレート誘導体
Bernstein et al. Synthesis and pharmacological characterization of a series of leukotriene analogs with antagonist and agonist activities
US5534533A (en) Carboxylate derivatives exhibiting phospholipase A2 inhibitory activity
EP0121806B1 (en) Pyrazolo(1,5-a)pyridine derivatives and compositions containing them
Miyano et al. (Acyloxy) benzophenones and (acyloxy)-4-pyrones. A new class of inhibitors of human neutrophil elastase

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKLA Lapsed

Effective date: 20041122